" Clinical experts and researchers have noted that 12.4% average weight loss at the highest dose places Foundayo meaningfully below the weight loss achieved with weekly injectable GLP-1 drugs
Excess body fat can lead to chronic inflammation and hormonal changes that promote cancer development
Gough, Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: current and future potentials
It is of critical importance that future studies directly evaluate sex-specific effects of these compounds to fully assess their clinical potential
Pharmacokinetic evaluation revealed markedly improved brain targeting, characterized by elevated intracerebral drug levels, and enhanced targeting efficiency
More serious symptoms, especially allergic reactions, chest pain, worsening headaches, or visual changes, should always be evaluated promptly